| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Algernon Pharmaceuticals Inc (OTCQB: AGNPF)
AGNPF Technical Analysis
5
| As on 12th Nov 2024 AGNPF STOCK Price closed @ 0.06 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.10 & Strong Sell for SHORT-TERM with Stoploss of 0.16 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AGNPFSTOCK Price
| Open | 0.06 | Change | Price | % |
| High | 0.06 | 1 Day | -0.01 | -14.29 |
| Low | 0.06 | 1 Week | 0.00 | 0.00 |
| Close | 0.06 | 1 Month | 0.00 | 0.00 |
| Volume | 1240 | 1 Year | -0.14 | -70.00 |
| 52 Week High 0.20 | 52 Week Low 0.04 | ||||
OTCQB USA Most Active Stocks
| SURG | 1.80 | 23.29% |
| FNMAS | 10.12 | 2.33% |
| FMCKJ | 9.73 | 0.83% |
| BMIX | 0.01 | % |
| FNMA | 3.16 | 4.98% |
| FMCC | 3.08 | 5.48% |
| BTCWF | 0.10 | 150.00% |
| EFSH | 0.36 | -7.69% |
| ALPP | 3.56 | 0.00% |
| ALPP | 3.56 | 0.00% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
| AGNPF Daily Charts |
AGNPF Intraday Charts |
Whats New @ Bazaartrend |
AGNPF Free Analysis |
|
|
AGNPF Important Levels Intraday
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
AGNPF Forecast November 2024
| 4th UP Forecast | 0.16 |
| 3rd UP Forecast | 0.13 |
| 2nd UP Forecast | 0.11 |
| 1st UP Forecast | 0.09 |
| 1st DOWN Forecast | 0.03 |
| 2nd DOWN Forecast | 0.01 |
| 3rd DOWN Forecast | -0.01 |
| 4th DOWN Forecast | -0.04 |
AGNPF Weekly Forecast
| 4th UP Forecast | 0.16 |
| 3rd UP Forecast | 0.13 |
| 2nd UP Forecast | 0.11 |
| 1st UP Forecast | 0.09 |
| 1st DOWN Forecast | 0.03 |
| 2nd DOWN Forecast | 0.01 |
| 3rd DOWN Forecast | -0.01 |
| 4th DOWN Forecast | -0.04 |
AGNPF Forecast2024
| 4th UP Forecast | 0.35 |
| 3rd UP Forecast | 0.26 |
| 2nd UP Forecast | 0.2 |
| 1st UP Forecast | 0.14 |
| 1st DOWN Forecast | -0.02 |
| 2nd DOWN Forecast | -0.08 |
| 3rd DOWN Forecast | -0.14 |
| 4th DOWN Forecast | -0.23 |
Algernon Pharmaceuticals Inc ( OTCQB USA Symbol : AGNPF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AGNPF Business Profile
Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of non?alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia. The company's lead candidate is NP-120, an N-methyl-d-aspartate (NMDA) receptor glutamate receptor antagonist, which targets NMDA-type subunit 2B (Glu2NB), as well as exhibits agonist activity for the Sigma-1 receptor, a chaperone protein up-regulated during endoplasmic reticulum stress. It is also developing AP-188 (N,N-Dimethyltryptamine), a psychedelic compound that is part of the tryptamine family for the treatment of ischemic stroke in humans. Algernon Pharmaceuticals Inc. has an agreement with Charles River Laboratories for preclinical studies of AP-188 for the company's stroke clinical research program. Algernon Pharmaceuticals Inc. is headquartered in Vancouver, Canada. Address: 700 West Pender Street, Vancouver, BC, Canada, V6C 1G8
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service